BlackRock Japan’s Dr. Reddy's Laboratories RDY Stock Holding History

BlackRock Japan’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,685	Closed	-$53K	–	1463
2015 Q4	$53K	Sell	5,685 -1,680	-23%	-$18.4K	﹤0.01%	1016
2015 Q3	$94K	Buy	7,365 +1,805	+32%	+$22.4K	﹤0.01%	873
2015 Q2	$62K	Buy	5,560 +1,690	+44%	+$18.7K	﹤0.01%	1040
2015 Q1	$44K	Hold	3,870	–	–	﹤0.01%	1082
2014 Q4	$39K	Hold	3,870	–	–	﹤0.01%	1132
2014 Q3	$41K	Hold	3,870	–	–	﹤0.01%	1079
2014 Q2	$33K	Buy	+3,870	New	+$32.5K	﹤0.01%	1096
2014 Q1	–	Sell	-945	Closed	-$8K	–	1441
2013 Q4	$8K	Hold	945	–	–	﹤0.01%	1293
2013 Q3	$7K	Hold	945	–	–	﹤0.01%	1282
2013 Q2	$7K	Buy	+945	New	+$6.9K	﹤0.01%	1283

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock Japan's RDY Position: Q1 2016 in Review

BlackRock Japan sold out of Dr. Reddy's Laboratories (RDY) in Q1 2016, closing a stake of 5,685 shares — an estimated $53K sold.

BlackRock Japan first reported a position in RDY in Q2 2013 and held it in 10 quarters. The position peaked at $94K in Q3 2015. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2016.

BlackRock Japan reported no remaining Dr. Reddy's Laboratories position as of Q1 2016 after selling out during the quarter.
BlackRock Japan sold 5,685 Dr. Reddy's Laboratories shares in Q1 2016, an estimated $53K.
BlackRock Japan first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 10 quarters.
BlackRock Japan's Dr. Reddy's Laboratories position peaked at $94K in Q3 2015.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.